SCHEMBL21717397

SCHEMBL21717397

c1ccc(-n2c3ccccc3c3ccc(-c4nc(-c5ccc6cc(-n7c8ccccc8c8cc9ccc(-n%10c%11ccccc%11c%11ccc%12ccccc%12c%11%10)cc9cc87)ccc6c5)nc5ccccc45)cc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
AURKA O14965 1/20 0.33
AURKB Q96GD4 1/20 0.33
GAA P10253 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.31
PTGER4 P35408 1/20 0.30
PDPK1 O15530 1/20 0.30
ROCK2 O75116 1/20 0.30
ROCK1 Q13464 1/20 0.30
PKN1 Q16512 1/20 0.30
PKN2 Q16513 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21213589 0.94 ATM (0.36) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21717334 0.94 ATM (0.38) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21717116 0.94 AURKA (0.35) ATMMEN1KMT2AF2F10
SCHEMBL21716497 0.93 ATM (0.38) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21717414 0.93 ATM (0.36) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21717130 0.93 ATM (0.36) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL20886591 0.92 ATM (0.40) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21716414 0.92 ATM (0.37) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21717380 0.92 ATM (0.37) ATMMEN1KMT2AKDM4EL3MBTL1
SCHEMBL21168886 0.92 ATM (0.39) ATMMEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ATM 3428/4885MEN1 200/4885KMT2A 878/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ATM 3428/4885MEN1 200/4885KMT2A 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.